nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—Bronchopneumonia—Thalidomide—leprosy	0.0605	0.0605	CcSEcCtD
Fondaparinux sodium—Swelling face—Dapsone—leprosy	0.0542	0.0542	CcSEcCtD
Fondaparinux sodium—Intestinal perforation—Thalidomide—leprosy	0.0334	0.0334	CcSEcCtD
Fondaparinux sodium—Venous thrombosis—Thalidomide—leprosy	0.0245	0.0245	CcSEcCtD
Fondaparinux sodium—Foetor hepaticus—Thalidomide—leprosy	0.0233	0.0233	CcSEcCtD
Fondaparinux sodium—Intestinal obstruction—Thalidomide—leprosy	0.0194	0.0194	CcSEcCtD
Fondaparinux sodium—Liver disorder—Thalidomide—leprosy	0.0194	0.0194	CcSEcCtD
Fondaparinux sodium—Cyanosis—Thalidomide—leprosy	0.0186	0.0186	CcSEcCtD
Fondaparinux sodium—Thrombosis—Thalidomide—leprosy	0.0186	0.0186	CcSEcCtD
Fondaparinux sodium—Tingling sensation—Thalidomide—leprosy	0.0164	0.0164	CcSEcCtD
Fondaparinux sodium—Cellulitis—Thalidomide—leprosy	0.0145	0.0145	CcSEcCtD
Fondaparinux sodium—Hyperbilirubinaemia—Thalidomide—leprosy	0.0145	0.0145	CcSEcCtD
Fondaparinux sodium—Hypocalcaemia—Thalidomide—leprosy	0.0144	0.0144	CcSEcCtD
Fondaparinux sodium—Oliguria—Thalidomide—leprosy	0.0143	0.0143	CcSEcCtD
Fondaparinux sodium—Drug interaction—Thalidomide—leprosy	0.0142	0.0142	CcSEcCtD
Fondaparinux sodium—Creatinine increased—Thalidomide—leprosy	0.0139	0.0139	CcSEcCtD
Fondaparinux sodium—Hepatocellular injury—Thalidomide—leprosy	0.0132	0.0132	CcSEcCtD
Fondaparinux sodium—Blood urea increased—Thalidomide—leprosy	0.0125	0.0125	CcSEcCtD
Fondaparinux sodium—Lightheadedness—Thalidomide—leprosy	0.0118	0.0118	CcSEcCtD
Fondaparinux sodium—Sepsis—Thalidomide—leprosy	0.0115	0.0115	CcSEcCtD
Fondaparinux sodium—Vascular purpura—Thalidomide—leprosy	0.0107	0.0107	CcSEcCtD
Fondaparinux sodium—Vision blurred—Dapsone—leprosy	0.0106	0.0106	CcSEcCtD
Fondaparinux sodium—Cardiac failure congestive—Thalidomide—leprosy	0.0106	0.0106	CcSEcCtD
Fondaparinux sodium—Renal failure acute—Thalidomide—leprosy	0.0104	0.0104	CcSEcCtD
Fondaparinux sodium—Vertigo—Dapsone—leprosy	0.0101	0.0101	CcSEcCtD
Fondaparinux sodium—Atrial fibrillation—Thalidomide—leprosy	0.0101	0.0101	CcSEcCtD
Fondaparinux sodium—Dermatitis bullous—Thalidomide—leprosy	0.01	0.01	CcSEcCtD
Fondaparinux sodium—Purpura—Thalidomide—leprosy	0.00994	0.00994	CcSEcCtD
Fondaparinux sodium—Cough—Dapsone—leprosy	0.00984	0.00984	CcSEcCtD
Fondaparinux sodium—Cardiac failure—Thalidomide—leprosy	0.00982	0.00982	CcSEcCtD
Fondaparinux sodium—Cerebrovascular accident—Thalidomide—leprosy	0.00978	0.00978	CcSEcCtD
Fondaparinux sodium—Pain in extremity—Thalidomide—leprosy	0.00958	0.00958	CcSEcCtD
Fondaparinux sodium—Cardiac arrest—Thalidomide—leprosy	0.00911	0.00911	CcSEcCtD
Fondaparinux sodium—Tachycardia—Dapsone—leprosy	0.00898	0.00898	CcSEcCtD
Fondaparinux sodium—Blood creatinine increased—Thalidomide—leprosy	0.00898	0.00898	CcSEcCtD
Fondaparinux sodium—Dehydration—Thalidomide—leprosy	0.00891	0.00891	CcSEcCtD
Fondaparinux sodium—Hypokalaemia—Thalidomide—leprosy	0.00872	0.00872	CcSEcCtD
Fondaparinux sodium—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00863	0.00863	CcSEcCtD
Fondaparinux sodium—Alanine aminotransferase increased—Thalidomide—leprosy	0.00845	0.00845	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Thalidomide—leprosy	0.00834	0.00834	CcSEcCtD
Fondaparinux sodium—Insomnia—Dapsone—leprosy	0.00832	0.00832	CcSEcCtD
Fondaparinux sodium—Dysphagia—Thalidomide—leprosy	0.00828	0.00828	CcSEcCtD
Fondaparinux sodium—Bronchospasm—Thalidomide—leprosy	0.00815	0.00815	CcSEcCtD
Fondaparinux sodium—Bronchitis—Thalidomide—leprosy	0.00796	0.00796	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Dapsone—leprosy	0.00752	0.00752	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Thalidomide—leprosy	0.00738	0.00738	CcSEcCtD
Fondaparinux sodium—Infestation—Thalidomide—leprosy	0.00738	0.00738	CcSEcCtD
Fondaparinux sodium—Acute coronary syndrome—Thalidomide—leprosy	0.00728	0.00728	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Dapsone—leprosy	0.00727	0.00727	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Dapsone—leprosy	0.00727	0.00727	CcSEcCtD
Fondaparinux sodium—Renal failure—Thalidomide—leprosy	0.00726	0.00726	CcSEcCtD
Fondaparinux sodium—Myocardial infarction—Thalidomide—leprosy	0.00724	0.00724	CcSEcCtD
Fondaparinux sodium—Haematuria—Thalidomide—leprosy	0.00704	0.00704	CcSEcCtD
Fondaparinux sodium—Epistaxis—Thalidomide—leprosy	0.00696	0.00696	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Thalidomide—leprosy	0.0066	0.0066	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Thalidomide—leprosy	0.00653	0.00653	CcSEcCtD
Fondaparinux sodium—Angiopathy—Thalidomide—leprosy	0.00601	0.00601	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Thalidomide—leprosy	0.00599	0.00599	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Thalidomide—leprosy	0.00597	0.00597	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Thalidomide—leprosy	0.00592	0.00592	CcSEcCtD
Fondaparinux sodium—Vomiting—Dapsone—leprosy	0.00585	0.00585	CcSEcCtD
Fondaparinux sodium—Malnutrition—Thalidomide—leprosy	0.00577	0.00577	CcSEcCtD
Fondaparinux sodium—Headache—Dapsone—leprosy	0.00576	0.00576	CcSEcCtD
Fondaparinux sodium—Flatulence—Thalidomide—leprosy	0.00569	0.00569	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Thalidomide—leprosy	0.00565	0.00565	CcSEcCtD
Fondaparinux sodium—Back pain—Thalidomide—leprosy	0.00558	0.00558	CcSEcCtD
Fondaparinux sodium—Nausea—Dapsone—leprosy	0.00546	0.00546	CcSEcCtD
Fondaparinux sodium—Vision blurred—Thalidomide—leprosy	0.00544	0.00544	CcSEcCtD
Fondaparinux sodium—Anaemia—Thalidomide—leprosy	0.00533	0.00533	CcSEcCtD
Fondaparinux sodium—Angioedema—Thalidomide—leprosy	0.00527	0.00527	CcSEcCtD
Fondaparinux sodium—Vertigo—Thalidomide—leprosy	0.00518	0.00518	CcSEcCtD
Fondaparinux sodium—Syncope—Thalidomide—leprosy	0.00517	0.00517	CcSEcCtD
Fondaparinux sodium—Palpitations—Thalidomide—leprosy	0.0051	0.0051	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Thalidomide—leprosy	0.00507	0.00507	CcSEcCtD
Fondaparinux sodium—Cough—Thalidomide—leprosy	0.00504	0.00504	CcSEcCtD
Fondaparinux sodium—Convulsion—Thalidomide—leprosy	0.005	0.005	CcSEcCtD
Fondaparinux sodium—Chest pain—Thalidomide—leprosy	0.00491	0.00491	CcSEcCtD
Fondaparinux sodium—Anxiety—Thalidomide—leprosy	0.0049	0.0049	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00488	0.00488	CcSEcCtD
Fondaparinux sodium—Confusional state—Thalidomide—leprosy	0.00475	0.00475	CcSEcCtD
Fondaparinux sodium—Oedema—Thalidomide—leprosy	0.00471	0.00471	CcSEcCtD
Fondaparinux sodium—Infection—Thalidomide—leprosy	0.00468	0.00468	CcSEcCtD
Fondaparinux sodium—Shock—Thalidomide—leprosy	0.00463	0.00463	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Thalidomide—leprosy	0.00462	0.00462	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Thalidomide—leprosy	0.00461	0.00461	CcSEcCtD
Fondaparinux sodium—Tachycardia—Thalidomide—leprosy	0.0046	0.0046	CcSEcCtD
Fondaparinux sodium—Skin disorder—Thalidomide—leprosy	0.00457	0.00457	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Thalidomide—leprosy	0.00455	0.00455	CcSEcCtD
Fondaparinux sodium—Anorexia—Thalidomide—leprosy	0.00449	0.00449	CcSEcCtD
Fondaparinux sodium—Hypotension—Thalidomide—leprosy	0.0044	0.0044	CcSEcCtD
Fondaparinux sodium—Insomnia—Thalidomide—leprosy	0.00426	0.00426	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Thalidomide—leprosy	0.00423	0.00423	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Thalidomide—leprosy	0.0042	0.0042	CcSEcCtD
Fondaparinux sodium—Somnolence—Thalidomide—leprosy	0.00419	0.00419	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Thalidomide—leprosy	0.00415	0.00415	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Thalidomide—leprosy	0.00409	0.00409	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Thalidomide—leprosy	0.00407	0.00407	CcSEcCtD
Fondaparinux sodium—Fatigue—Thalidomide—leprosy	0.00406	0.00406	CcSEcCtD
Fondaparinux sodium—Constipation—Thalidomide—leprosy	0.00403	0.00403	CcSEcCtD
Fondaparinux sodium—Pain—Thalidomide—leprosy	0.00403	0.00403	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Thalidomide—leprosy	0.00388	0.00388	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Thalidomide—leprosy	0.00385	0.00385	CcSEcCtD
Fondaparinux sodium—Urticaria—Thalidomide—leprosy	0.00374	0.00374	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Thalidomide—leprosy	0.00372	0.00372	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Thalidomide—leprosy	0.00372	0.00372	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Thalidomide—leprosy	0.00347	0.00347	CcSEcCtD
Fondaparinux sodium—Asthenia—Thalidomide—leprosy	0.00338	0.00338	CcSEcCtD
Fondaparinux sodium—Pruritus—Thalidomide—leprosy	0.00333	0.00333	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Thalidomide—leprosy	0.00322	0.00322	CcSEcCtD
Fondaparinux sodium—Dizziness—Thalidomide—leprosy	0.00311	0.00311	CcSEcCtD
Fondaparinux sodium—Vomiting—Thalidomide—leprosy	0.00299	0.00299	CcSEcCtD
Fondaparinux sodium—Rash—Thalidomide—leprosy	0.00297	0.00297	CcSEcCtD
Fondaparinux sodium—Dermatitis—Thalidomide—leprosy	0.00297	0.00297	CcSEcCtD
Fondaparinux sodium—Headache—Thalidomide—leprosy	0.00295	0.00295	CcSEcCtD
Fondaparinux sodium—Nausea—Thalidomide—leprosy	0.0028	0.0028	CcSEcCtD
